Disorders of copper transport

British Medical Bulletin

Volumn 55, Issue 3, 1999, Pages 544-555

  Cox, Diane W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; COPPER; ENZYME; MARKER; MEMBRANE PROTEIN; PROTEIN;

CELL TRANSPORT; DIAGNOSIS; HUMAN; MENKES SYNDROME; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOXICITY; WILSON DISEASE; YEAST;

EID: 0032711538     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1258/0007142991902619     Document Type: Review

References (38)

1. Mertz M. The essential trace elements. Science 1981; 213: 1332-6
2. Cox DW. Genes of the copper pathway. Am J Hum Genet 1995; 56: 828-34
3. Linder MC. The Biochemistry of Copper. New York: Plenum, 1991
4. Danks DM. Disorders of copper transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (Eds) The Molecular and Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1995: 4125-58
5. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85
6. Vulpe C, Levinson B, Whitney S, Packman S, Gitschier J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase [erratum in Nat Genet 1993; 3: 273]. Nat Genet 1993; 3: 7-13
7. Chelly J, Turner Z, Tonnesen T et al. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat Genet 1993; 3: 14-19
8. Mercer JF, Livingston J, Hall B et al. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat Genet 1993; 3: 20-25
9. Odermatt A, Suter H, Krapf R, Solioz M. Primary structure of two P-type ATPases involved in copper homeostasis in Enterococcus hirae. J Biol Chem 1993; 268: 12775-9
10. Frydman M, Bonne-Tamir B, Farrer LA et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci USA 1985; 82: 1819-21
11. Bowcock AM, Farrer LA, Hebert JM, Bale AE, Cavalli-Sforza LL. A contiguous linkage map of chromosome 13q with 39 distinct loci separated on average by 5.1 centimorgans. Genomics 1991; 11: 517-29
12. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene [erratum in Nat Genet 1994; 6: 214]. Nat Genet 1993; 5: 327-37
13. Tanzi RE, Petrukhin KE, Chernov I et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993; 5: 344-50
14. Yuan DS, Stearman R, Dancis A et al. The Menkes/Wilson disease gene homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake. Proc Natl Acad Sci USA 1995; 92: 2632-6
15. Valentine JS, Gralla EB. Delivering copper inside yeast and human cells. Science 1997; 278: 817-8
16. Vulpe CD, Kuo YM, Murphy TL et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet 1999; 21: 195-9
17. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Atchbold GPR. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Quart J Med 1994; 87: 663-70
18. Yoshida K, Furihata K, Takeda S et al. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 1995; 9: 267-72
19. Harris ZL, Takahashi Y, Miyajima H et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 1995; 92: 2539-43
20. Petris MJ, Mercer JF, Culvenor JG et al. Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J 1996; 15: 6084-95
21. Hung IH, Suzuki M, Yamaguchi Y et al. Biochemical characterization of the wilson disease protein and functional expression in the yeast Saccharomyces cerevisiae. J Biol Chem 1997; 272: 21461-6
22. Turner Z, Horn N. Menkes disease: recent advances and new aspects. J Med Genet 1997; 34: 265-74
23. Turner Z, Lund C, Tolshave J et al. Identification of point mutations in 41 unrelated patients affected with Menkes disease. Am J Hum Genet 1997; 60: 63-71
24. Christodoulou J, Danks DM, Sarkar B et al. Early treatment of Menkes disease with parenteral copper-histidine: long-term follow-up of four treated patients. Am J Med Genet 1998; 76: 154-64
25. Mercer JF. Menkes syndrome and animal models. Am J Clin Nutr 1998; 67: 1022S-8S
26. Masson W, Hughes H, Papworth D, Boyd Y, Horn N. Abnormalities of copper accumulation in cell lines established from nine different alleles of mottled are the same as those found in Menkes disease. J Med Genet 1997; 34: 729-32
27. Steindl P, Ferenci P, Dienes HP et al. Wilson's disease in patients with liver disease: a diagnostic challenge. Gastroenterology 1998; 113: 212-8
28. Thomas GR, Roberts EA, Walshe JM, Cox DW. Haplotypes and mutations in Wilson disease. Am J Hum Genet 1995; 56: 1315-9
29. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences [erratum in Nat Genet 1995; 9: 451]. Nat Genet 1995; 9: 210-7
30. Wu J, Forbes JR, Chen HS, Cox DW. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet 1994; 7: 541-5
31. Forbes JR, Hsi G, Cox DW. Role of the copper-binding domain in the copper transport function of ATP7B, the P-type ATPase defective in Wilson disease. J Biol Chem 1999; 274: 12408-13
32. Cox DW. Molecular advances in Wilson disease. In: Boyer JL, Ockner RK (Eds) Progress in Liver Diseases. Philadelphia: Saunders, 1996: 245-64
33. Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Quart J Med 1973; 42: 441-52
34. Brewer GJ, Johnson V, Dick RD et al. Treatment of Wilson disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 1996; 53: 1017-25
35. Hoogenraad TU, Koevoet R, DeRuyter-Korver EGWM. Oral zinc sulphate as long term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979; 18: 205-11
36. Britton RS. Metal-induced hepatotoxicity. Semin Liver Dis 1996; 16: 3-12
37. Sokol R, Twedt D, McKim JM et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology 1994; 107: 1788-98
38. van de Sluis BJA, Breen M, Nanjir M et al. Genetic mapping of the copper toxicosis locus in Bedlington terriers to dog chromosome 10, in a region syntenic to human chromosome region 2p13- p16. Hum Mol Genet 1999; 8: 501-7